Cantharidin and norcantharidin impair stemness of pancreatic cancer cells by repressing the β-catenin pathway and strengthen the cytotoxicity of gemcitabine and erlotinib

Author：                

Publisher： Spandidos Publications

E-ISSN： 1791-2423|47|5|1912-1922

ISSN： 1019-6439

Source： International Journal of Oncology, Vol.47, Iss.5, 2015-01, pp. : 1912-1922

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

MicroRNA-29a induces resistance to gemcitabine through the Wnt/β-catenin signaling pathway in pancreatic cancer cells

By                  

International Journal of Oncology, Vol. 43, Iss. 4, 2013-01 ,pp. : 1066-1072

Spandidos Publications

Access to resources Recommend Favorite

Erlotinib or capecitabine with gemcitabine in pancreatic cancer?

By de Jager Jenny   Stebbing Justin  

Future Oncology, Vol. 2, Iss. 2, 2006-04 ,pp. : 161-163

Future Medicine

Access to resources Recommend Favorite

Tamoxifen enhances the anticancer effect of cantharidin and norcantharidin in pancreatic cancer cell lines through inhibition of the protein kinase C signaling pathway

By  

Oncology Letters, Vol. 9, Iss. 2, 2015-01 ,pp. : 837-844

Spandidos Publications

Access to resources Recommend Favorite

Aplasia Ras homolog member I expression induces apoptosis in renal cancer cells via the β-catenin signaling pathway

By  

Molecular Medicine Reports, Vol. 11, Iss. 1, 2015-01 ,pp. : 475-481

Spandidos Publications

Access to resources Recommend Favorite

β-catenin deacetylation is essential for WNTinduced proliferation of breast cancer cells

By          

Molecular Medicine Reports, Vol. 9, Iss. 3, 2014-01 ,pp. : 973-978

Spandidos Publications

Access to resources Recommend Favorite